Simplex Trading
NGNE icon

Simplex Trading’s Neurogene NGNE Stock Holding History

Simplex Trading’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.4K Buy
2,800
+2,700
+2,700% +$52.3K ﹤0.01% 5738
2025
Q4 		$2.06K Sell
100
-4,200
-98% -$105K ﹤0.01% 7820
2025
Q3 		$74K Sell
4,300
-4,500
-51% -$90.4K ﹤0.01% 6068
2025
Q2 		$131K Buy
8,800
+2,800
+47% +$43.9K ﹤0.01% 4963
2025
Q1 		$70K Buy
+6,000
New +$104K ﹤0.01% 5447
2022
Q2 		– Sell
-6,470
Closed -$243K – 10689
2022
Q1 		$243K Buy
6,470
+6,340
+4,877% +$370K ﹤0.01% 4867
2021
Q4 		$12K Buy
+130
New +$15.8K ﹤0.01% 8875
2021
Q1 		– Sell
-2
Closed -$43K – 9629
2020
Q4 		$43K Hold
2
– – ﹤0.01% 6342
2020
Q3 		$48K Buy
+2
New +$484 ﹤0.01% 5643
2020
Q2 		– Sell
-1
Closed -$261 – 6497
2020
Q1 		$26K Sell
1
-4
-80% -$823 ﹤0.01% 5743
2019
Q4 		$118K Buy
+5
New +$498 ﹤0.01% 4341
2018
Q4 		– Sell
-11
Closed -$63K – 7546
2018
Q3 		$63K Sell
11
-12
-52% -$708 ﹤0.01% 4934
2018
Q2 		$124K Buy
+23
New +$6K ﹤0.01% 4040
2018
Q1 		– Sell
-1
Closed -$4K – 6617
2017
Q4 		$4K Buy
+1
New +$234 ﹤0.01% 4712
2017
Q1 		– Sell
-3
Closed -$3K – 6571
2016
Q4 		$3K Hold
3
– – ﹤0.01% 4770
2016
Q3 		$3K Buy
+3
New +$605 ﹤0.01% 4716

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Simplex Trading's NGNE Position: Q1 2026 in Review

Simplex Trading increased its Neurogene (NGNE) stake by 44% in Q1 2026, buying an estimated $523 and bringing the position to 89 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #8410.

Simplex Trading first reported a position in NGNE in Q4 2016 and has held it in 19 quarters since. The position peaked at $96K in Q1 2018. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • Simplex Trading held 89 shares of Neurogene worth $1.79K as of Q1 2026.
  • Simplex Trading bought 27 Neurogene shares in Q1 2026, an estimated $523.
  • Neurogene made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8410 holding.
  • Simplex Trading first reported a position in Neurogene in Q4 2016 and has held it in 19 quarters since.
  • Simplex Trading's Neurogene position peaked at $96K in Q1 2018.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.